Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the safety and efficacy of ANG-3777 in preventing AKI
compared to placebo when administered to patients at risk for developing acute kidney injury
(AKI) following cardiac surgical procedures involving cardiopulmonary bypass (CPB).
Phase:
Phase 2
Details
Lead Sponsor:
Angion Biomedica Corp
Collaborators:
Clinical Accelerator CTI Clinical Trial and Consulting Services Everest Clinical Research